<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Package index â€¢ drugdevelopR</title><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet"><script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet"><link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet"><script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Package index"></head><body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">drugdevelopR</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">1.0.2</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto"><li class="active nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles"><li><a class="dropdown-item" href="../articles/Introduction-to-drugdevelopR.html">Introduction to planning phase II and phase III trials with drugdevelopR</a></li>
    <li><a class="dropdown-item" href="../articles/Package_validation.html">Package validation</a></li>
    <li><hr class="dropdown-divider"></li>
    <li><a class="dropdown-item" href="../articles/index.html">More articles...</a></li>
  </ul></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul><ul class="navbar-nav"><li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json"></form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/Sterniii3/drugdevelopR/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul></div>


  </div>
</nav><div class="container template-reference-index">
<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>Package index</h1>
    </div>

    <div class="section level2">
      <h2 id="basic-setting">Basic setting<a class="anchor" aria-label="anchor" href="#basic-setting"></a></h2>

      <div class="section-desc"><p>Optimally plan basic phase II/III drug development programs.</p></div>


    </div><div class="section level2">




      <dl><dt>

          <code><a href="optimal_tte.html">optimal_tte()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning with time-to-event endpoint</dd>
      </dl><dl><dt>

          <code><a href="optimal_binary.html">optimal_binary()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning with binary endpoint</dd>
      </dl><dl><dt>

          <code><a href="optimal_normal.html">optimal_normal()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning with normally distributed endpoint</dd>
      </dl></div><div class="section level2">
      <h2 id="bias-adjustment">Bias adjustment<a class="anchor" aria-label="anchor" href="#bias-adjustment"></a></h2>

      <div class="section-desc"><p>As phase III is only conducted in case of promising phase II results, treatment effect estimates from phase II generally overestimate the treatment effect. The following methods supply bias adjustment strategies for optimal program planning.</p></div>


    </div><div class="section level2">




      <dl><dt>

          <code><a href="optimal_bias.html">optimal_bias()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning for time-to-event endpoints when discounting phase II results</dd>
      </dl><dl><dt>

          <code><a href="optimal_bias_binary.html">optimal_bias_binary()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning when discounting phase II results with binary endpoint</dd>
      </dl><dl><dt>

          <code><a href="optimal_bias_normal.html">optimal_bias_normal()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning when discounting phase II results with normally distributed endpoint</dd>
      </dl></div><div class="section level2">
      <h2 id="multi-trial-programs">Multi-trial programs<a class="anchor" aria-label="anchor" href="#multi-trial-programs"></a></h2>

      <div class="section-desc"><p>More and more often, regulatory authorities require more than one confirmatory phase III study to have delivered a significant result. With the following methods, the planning of multi-trial programs can be optimized.</p></div>


    </div><div class="section level2">




      <dl><dt>

          <code><a href="optimal_multitrial.html">optimal_multitrial()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning where several phase III trials are performed for time-to-event endpoints</dd>
      </dl><dl><dt>

          <code><a href="optimal_multitrial_binary.html">optimal_multitrial_binary()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning where several phase III trials are performed</dd>
      </dl><dl><dt>

          <code><a href="optimal_multitrial_normal.html">optimal_multitrial_normal()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning where several phase III trials are performed</dd>
      </dl></div><div class="section level2">
      <h2 id="multi-arm-trials">Multi-arm trials<a class="anchor" aria-label="anchor" href="#multi-arm-trials"></a></h2>

      <div class="section-desc"><p>An efficient way of discovering effective treatments among a range of treatment choices is the conduct of multi-arm trials, which can be optimally planned using the following methods.</p></div>


    </div><div class="section level2">




      <dl><dt>

          <code><a href="optimal_multiarm.html">optimal_multiarm()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning for multi-arm programs with time-to-event endpoint</dd>
      </dl><dl><dt>

          <code><a href="optimal_multiarm_binary.html">optimal_multiarm_binary()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning for multi-arm programs with binary endpoint</dd>
      </dl><dl><dt>

          <code><a href="optimal_multiarm_normal.html">optimal_multiarm_normal()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning for multi-arm programs with normally distributed endpoint</dd>
      </dl></div><div class="section level2">
      <h2 id="multiple-endpoints">Multiple endpoints<a class="anchor" aria-label="anchor" href="#multiple-endpoints"></a></h2>

      <div class="section-desc"><p>In some trials, multiple endpoints may be of interest. Drug development programs with multiple endpoints can be optimized using the following methods.</p></div>


    </div><div class="section level2">




      <dl><dt>

          <code><a href="optimal_multiple_tte.html">optimal_multiple_tte()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning for programs with multiple time-to-event endpoints</dd>
      </dl><dl><dt>

          <code><a href="optimal_multiple_normal.html">optimal_multiple_normal()</a></code>

        </dt>
        <dd>Optimal phase II/III drug development planning for programs with multiple normally distributed endpoints</dd>
      </dl></div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside></div>


    <footer><div class="pkgdown-footer-left">
  <p>Developed by Stella Erdmann, Johannes Cepicka, Marietta Kirchner, Meinhard Kieser, Lukas D. Sauer.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.1.</p>
</div>

    </footer></div>





  </body></html>

